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Abstract
To identify genetic contributions to type 2 diabetes (T2D) and related glycemic traits (fasting
glucose, fasting insulin, and HbA1c), we conducted genome-wide association analyses
(GWAS) in up to 7,178 Chinese subjects from nine provinces in the China Health and Nutri-
tion Survey (CHNS). We examined patterns of population structure within CHNS and found
that allele frequencies differed across provinces, consistent with genetic drift and population
substructure. We further validated 32 previously described T2D- and glycemic trait-loci,
including G6PC2 and SIX3-SIX2 associated with fasting glucose. At G6PC2, we replicated
a known fasting glucose-associated variant (rs34177044) and identified a second signal
(rs2232326), a low-frequency (4%), probably damaging missense variant (S324P). A variant
within the lead fasting glucose-associated signal at SIX3-SIX2 co-localized with pancreatic
islet expression quantitative trait loci (eQTL) for SIX3, SIX2, and three noncoding transcripts.
To identify variants functionally responsible for the fasting glucose association at SIX3-
SIX2, we tested five candidate variants for allelic differences in regulatory function. The
rs12712928-C allele, associated with higher fasting glucose and lower transcript expression
level, showed lower transcriptional activity in reporter assays and increased binding to GABP
compared to the rs12712928-G, suggesting that rs12712928-C contributes to elevated fast-
ing glucose levels by disrupting an islet enhancer, resulting in reduced gene expression.
Taken together, these analyses identified multiple loci associated with glycemic traits across
China, and suggest a regulatory mechanism at the SIX3-SIX2 fasting glucose GWAS locus.
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Author summary
Type 2 diabetes risk and levels of glucose, insulin, and HbA1c are heritable traits corre-
lated with risk of other diseases and mortality. To identify genetic variants associated with
these traits, we studied up to 7,178 men and women from nine provinces in China. We
found established variants that could affect fasting glucose located in or near genes named
G6PC2 and SIX3. One of the variants at G6PC2 changes the protein sequence and is pre-
dicted to affect how the protein functions. Variants located near SIX3 that are associated
with levels of glucose are also associated with levels of expression of the genes SIX3 and
SIX2 in pancreatic islets. These variants are located in a genomic region predicted to
enhance gene expression. We used laboratory assays to show that alleles at one variant,
rs12712928, demonstrate significant differences in transcriptional activity, suggesting that
this variant influences levels of the SIX3 and SIX2 genes in islets, ultimately increasing glu-
cose levels.
Introduction
Type 2 diabetes (T2D) is a chronic disease affecting over 422 million people worldwide[1] with
over 30% of cases occurring in East Asian populations [2]. Large-scale genome-wide associa-
tion studies (GWAS) have identified >100 loci associated with T2D and>80 loci associated
with fasting glucose, fasting insulin, and glycated hemoglobin (HbA1c), many of which have
also been implicated in T2D susceptibility [3–6]. While the largest GWAS of glycemic traits
and T2D to date have been performed in populations of predominantly European ancestry [3,
6–9], other studies have identified glycemic trait and T2D associations in East Asian individu-
als [5, 10, 11]. As glycemic trait profiles, allele frequencies, and environmental contributions
differ between populations, continued investigation of genetic factors can discover additional
loci influencing inter-individual variation in fasting glucose, fasting insulin, and HbA1c levels
and T2D.
A new resource for genetic analyses, the China Health and Nutrition Survey (CHNS) is an
ongoing, household-based, longitudinal survey aimed at examining economic, sociological,
demographic, and health questions in a diverse Chinese population [12]. Using a multistage
random-cluster design and stratified probability sampling to select counties and cities, data
were collected from 228 communities across nine provinces (Guangxi, Guizhou, Heilongjiang,
Henan, Hubei, Hunan, Jiangsu, Liaoning, and Shandong) that constituted 44% of China’s pop-
ulation as of the 2009 census. In addition to nearly 30 years of longitudinal survey data col-
lected during 9 survey rounds from 1989–2011, quantitative biomarker measurements and
DNA are available on 8,403 subjects in the CHNS.
Individual GWAS loci can harbor multiple association signals. More than one association
signal has been reported at G6PC2 and PCSK1 for fasting glucose and at KCNQ1, ANKRD55,
CDKN2A/B,DGKB,HNF4A, and CCND2 for T2D [5]. Imputation reference panels generated
from large sample sizes can facilitate identification of additional signals. For non-European
populations, the 1000 Genomes Phase 3 reference panel is currently the most comprehensive,
containing information for more than 88 million variants in >2,500 individuals from 26
diverse populations [13]. Identification of additional association signals at trait-associated loci
could explain additional heritability and provide further insights into the biology between the
locus and the trait or disease.
GWAS have been an efficient method for studying genetic factors influencing biological
mechanisms underlying glycemic traits and T2D, but for many of the identified loci, the
CHNS glycemic trait GWAS and SIX2-SIX3 regulatory variant
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underlying gene(s), direction of effect, and disease mechanism are largely unknown [14]. For
variants located in non-coding regions of the genome, bioinformatic datasets can be used to
annotate and predict regulatory variants, target genes, and direction of effect [15–18], and
these variants can be tested for allelic differences in regulatory activity with in vitro laboratory
assays [19, 20]. For example, among previous functional studies of variants associated with
fasting glucose at the G6PC2-ABCB11 locus, two variants in the promoter were shown to affect
G6PC2 expression levels by altering FOXA2 binding, and two variants located in the third
intron of G6PC2were shown to affect G6PC2 splicing [21–23]. However, the majority of the
glycemic trait-associated variants have not been examined.
To further clarify the genetic contributions to normal variation in glycemic traits in a
multi-provincial Chinese population, we performed a GWAS of fasting glucose, insulin,
and HbA1c levels and T2D in subjects from the CHNS, using genetic data imputed to 1000
Genomes Phase 3 in up to 7,178 subjects [12]. We examined the population substructure
within the CHNS and evaluated candidate functional regulatory variants at one locus using
annotation and in vitro laboratory assays.
Results
CHNS population structure
To evaluate population substructure among 8,403 CHNS subjects with genotype data available,
we constructed principal components (PCs) using a subset of variants (MAF > 0.05; pairwise
LD r2 <0.02 in a sliding window of 50 variants). Compared to HapMap 3 populations, the
CHNS participants clustered closely with the Han Chinese in Beijing (CHB), the Han Chinese
in Denver (CHD), and the Japanese in Tokyo (JPT) populations, with greater diversity than
any of these populations (S1A Fig). A comparison to only the East Asian samples showed
more clearly that the distribution of the CHNS extends beyond that of the CHB, CHD, and
JPT samples (S1B Fig). Within the CHNS, the subjects showed two axes of diversity (Fig 1, S2
Fig). PC1, which explained 4.2% of the variance, appeared to cluster by province, while PC2,
explaining 0.6% of the variance, showed diversity among subjects within the Guangxi and Gui-
zhou provinces in southern China. PC2 could be partially explained by differences in self-
reported ethnicity, particularly among subjects from the Guizhou province, as PC2 appeared
to characterize the Miao and Buyi ethnic groups (S3 Fig). To account for population substruc-
ture in subsequent association analyses with glycemic traits, we included PC1 as a covariate
and performed analyses using an efficient mixed model approach that accounts for sample
structure between individuals [24].
GWAS results
We performed genome-wide association analyses of fasting glucose and fasting insulin levels
in up to 8,045,193 genotyped and imputed variants (MAF >0.01) from 5,786 non-diabetic
individuals in the CHNS who provided fasting blood samples (S1 Table, S4 Fig). We also per-
formed a genome-wide association analysis of HbA1c in 7,178 nondiabetic individuals who
provided fasting or non-fasting samples. In addition, 5,731 unrelated subjects were used to
assess variant association with T2D status, including 748 cases and 4,983 controls. For each
trait, we also searched for additional signals by conditioning on the lead variants (reciprocal
conditional analyses). Overall, a majority of CHNS subjects were female (54%) with a normal
BMI (mean = 23.2 kg/m2), and subjects with T2D were older (cases: 59.7 years; controls: 51.2
years) with a higher BMI, higher fasting glucose levels, and higher fasting insulin levels (S1
Table).
CHNS glycemic trait GWAS and SIX2-SIX3 regulatory variant
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Analysis of fasting glucose confirmed eight loci previously identified in East Asian and
European samples (G6PC2, SIX3-SIX2, PROX1, ABCB11,GCK, KANK1,GLIS3, and TCF7L2;
S2 Table), two of which achieved genome-wide significance (rs34177044, near G6PC2, P = 6.9
x 10−12, Fig 2; rs895636, near SIX3-SIX2, P = 2.3 x 10−8, Table 1, Fig 3A, S5 Fig) [11, 25–27]. At
Fig 1. Principal components analysis of allele frequency for 8,403 subjects in the China Health and Nutrition Survey. Dots representing each subject are
colored by the province in which they reside.
https://doi.org/10.1371/journal.pgen.1007275.g001
Fig 2. Fasting glucose locus near G6PC2 exhibits two association signals in the CHNS. The first association signal,
rs34177044 (red diamond) shows the strongest association in the initial unconditioned analysis of fasting glucose.
Coding variant rs2232326 (S324P; blue diamond), remained locus-wide significant after conditioning on rs34177044.
The diamonds indicate the lead variants, which exhibited the strongest evidence of association at the locus among 1000
Genomes Project Phase 3-imputed variants. Variants are colored based on LD with the lead variants, rs34177044 (red)
and rs2232326 (blue) within 8,403 CHNS subjects.
https://doi.org/10.1371/journal.pgen.1007275.g002
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these two loci, we used stepwise conditional analyses to identify additional association signals
at a locus-wide threshold of P<1 x 10−5. Conditional analysis including rs34177044 at the
G6PC2 locus revealed a second signal (rs2232326, MAF = 0.04, Punconditioned = 1.8 x 10−9,
Pconditioned = 2.0 x 10−6, Fig 2). When conditioning only on rs2232326, rs34177044 was attenu-
ated but remained significantly associated with fasting glucose (Pconditioned = 7.0 x 10−9); the
attenuation suggests the two signals are distinct yet not fully independent. Haplotype analyses
(S3 Table) and regression models containing an interaction term with both variants (P = 0.69)
do not suggest a haplotype effect between the two signals, providing further evidence that the
two signals are separate. While conditional analyses could be influenced by the moderate
imputation quality of rs34177044 (r2 = 0.70) in CHNS, genotypes from the 1000 Genomes
project show that the minor allele of rs2232326 is only inherited with the major allele of
rs34177044 (East Asian LD r2 = 0.04, D’ = 1.0). No additional association signals were identi-
fied at the SIX3-SIX2 locus (S5 Fig).
The lead variant in the second signal at G6PC2 (rs2232326) is a missense variant (S324P).
Amino acid 324 is located in a helix spanning the cell membrane [28], and the substitution of a
proline for a serine in the middle of a helix may add kinks to the protein [29]. In addition,
both SIFT and PolyPhen [30] predict this variant to be “probably damaging”, suggesting that
it may affect function of the G6PC2 protein. Based on data from 1000 Genomes Phase 3,
rs2232326 is rare in all ancestry populations (MAF: African, 0.2%; Admixed American, 0.3%;
European, 0.3%; South Asian, 0.3%) except in East Asians (MAF 5%), and it has few (Admixed
American, rs34102076; East Asian, rs139014876), to no (African, European, and South Asian)
proxy variants (LD r2>0.80). This variant contributed to a significant G6PC2 gene-based asso-
ciation with glucose in Europeans [31] and other protein-coding variants within G6PC2 have
been individually associated with fasting glucose levels (e.g. rs492594, rs138726309, rs2232323)
[21]. In the CHNS, rs492594 was nominally associated with fasting glucose levels (P = 0.002);
other previously described coding variants were either monomorphic or did not pass imputa-
tion quality control thresholds in CHNS (S4 Table).
We examined whether the strength of fasting glucose associations at SIX3-SIX2 and G6PC2
varied by province (Table 2). At rs895636 (SIX3-SIX2), the minor allele frequencies (MAF) dif-
fered by as much as 0.12 between provinces. Most of the provinces in which individuals have a
relatively lower minor allele frequency (0.35–0.38) showed a stronger association between the
variant and fasting glucose levels than similarly sized samples of individuals with higher MAF
Table 1. Signals associated with levels of quantitative glycemic traits among non-diabetic subjects in CHNS.
Locus SNP Chr Position EA/NEA EAF Imputation r2 Genotype Beta SE P-value
Fasting Glucose
SIX3-SIX2 rs895636 2 45,188,353 T/C 0.40 GT 2124/2709/953 0.099 0.018 2.3 x 10−8
G6PC2 rs34177044 2 169,754,485 A/G 0.37 0.70 2043/2935/808 0.145 0.021 6.9 x 10−12
G6PC2 rs2232326 2 169,764,491 T/C 0.96 GT 5281/488/17 0.252 0.042 1.8 x 10−9
HbA1c
FN3KRP rs9895455 17 80,683,980 T/C 0.49 0.97 1821/3504/1853 0.095 0.018 1.0 x 10−7
Fasting Insulin
CNTN6 rs13078376 3 932,902 C/T 0.69 0.69 2637/2688/484 0.124 0.024 3.2 x 10−7
Results are shown if the association signal reached genome-wide significance (P<5x10-8) or is the strongest association if no signals reached genome-wide significance.
Trait values were adjusted for age, age2, BMI, PC1, and sex. Chromosome positions are based on hg19. Effect alleles are associated with higher trait values. Beta estimates
reflect per allele effects of variants on inverse normal transformed traits. CHNS, China Health and Nutrition Survey; chr, chromosome; EA, effect allele; NEA, noneffect
allele; EAF, effect allele frequency; SE, standard error; GT, genotyped
https://doi.org/10.1371/journal.pgen.1007275.t001
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Fig 3. Pancreatic islet eQTL colocalizes with the fasting glucose GWAS locus. (A) rs895636 (purple diamond)
shows the strongest association with fasting glucose in the CHNS. Variants are colored based on East Asian LD from
1000 Genomes Project Phase 3. (B) rs12712929 (purple diamond) shows the strongest association with expression of
SIX3 in pancreatic islets in European ancestry individuals. Variants are colored based on European LD from 1000
Genomes Project Phase 3. (C) Although the LD r2 between rs895636 and rs12712929 is moderate in both European
CHNS glycemic trait GWAS and SIX2-SIX3 regulatory variant
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of 0.43–0.47. The opposite pattern was observed at rs2232326 (G6PC2), for which the province
in which the largest MAF (0.09) showed the strongest association with fasting glucose levels.
The allele associated with higher levels of fasting glucose trended from less frequent in the
northern provinces (MAF = 0.02) to more frequent in the southern provinces (MAF = 0.09).
Although allele frequencies between provinces were not statistically different, observed allele
frequency differences are consistent with genetic drift and the observed population substruc-
ture (Fig 1) [32], demonstrating that study samples from across China have differing power to
detect specific associations.
Analysis of fasting insulin validated (P<0.05) two loci previously reported in European
and Hispanic samples (PPARG and LOC284930; S5 Table) [33, 34] and did not reveal any
genome-wide significant loci (Table 1). The most significant association was identified near
CNTN6 (rs13078376, P = 3.22 x 10−7; Supplementary Materials, S6 Fig). Previous studies have
demonstrated genome-wide significant associations between variants approximately 1 Mb
upstream of the CNTN6 gene and both fasting insulin (rs9841287) [33] and HbA1c levels
(rs892295) [35], although the rs13078376 is not a proxy for either of the two previously
reported variants (East Asian LD r2<0.01). Data from the CHNS strengthen the evidence for
these nominally significant loci near CNTN6.
Analysis of HbA1c validated (P<0.05) nine loci previously identified in East Asians and
Europeans (FN3KRP,MYO9B, PIEZO1, ANK1,GCK, SPTA1, HBS1L,MTNR1B, and ABCB11;
S6 Table) [10, 36, 37], and did not reveal any genome-wide significant loci. The most signifi-
cant variant was located within an intron of FN3KRP (rs9895455, P = 3.5 x 10−7; Supplemen-
tary Materials, S7 Fig). rs9895455 is in high LD (East Asian, r2 = 0.99) with a variant previously
reported to be associated with HbA1c in East Asians (rs1046875) [10]. Three additional vari-
ants in high LD with rs9895455 have previously demonstrated moderate associations in
and East Asian populations (1000G Phase 3), one variant, rs12712928, exhibits high LD (r2>0.80) with rs895636 in
East Asians and rs12712929 in Europeans (arrow). Red font indicates variants above r2 of 0.80. Vertical bars indicate
the genomic regions examined for allelic differences in regulatory function.
https://doi.org/10.1371/journal.pgen.1007275.g003
Table 2. Comparison by province of genome-wide significant signals for fasting glucose.
Province N SIX3-SIX2 G6PC2
rs895636-T rs34177044-A rs2232326-C
MAF Beta P-value MAF Beta P-value MAF Beta P-value
Heilongjiang 736 0.35 0.134 0.007 0.35 0.194 0.0009 0.02 -0.199 0.22
Liaoning 564 0.37 0.036 0.48 0.36 0.172 0.006 0.02 -0.365 0.03
Shandong 625 0.36 0.152 0.003 0.40 0.156 0.01 0.03 -0.232 0.16
Jiangsu 723 0.38 0.125 0.004 0.39 0.086 0.11 0.04 -0.007 0.95
Henan 732 0.36 0.120 0.009 0.37 0.076 0.14 0.03 -0.405 0.0009
Hubei 349 0.43 0.086 0.25 0.38 0.130 0.14 0.04 -0.151 0.42
Hunan 660 0.44 0.057 0.21 0.36 0.084 0.13 0.05 -0.305 0.003
Guizhou 461 0.43 0.128 0.07 0.36 0.188 0.03 0.07 -0.178 0.22
Guangxi 936 0.47 0.057 0.14 0.36 0.157 0.001 0.09 -0.277 3.5 x 10−5
All Subjects 5,786 0.40 0.099 2.3 x 10−8 0.40 0.145 6.9 x 10−12 0.04 -0.252 1.8 x 10−9
Provinces are ordered based on geographical location from north to south. Trait values were adjusted for age, age2, BMI, PC1, and sex, and the residuals were then
inverse normal transformed. Beta estimates reflect per allele effects of variants on inverse normal transformed traits. Only non-diabetic subjects were included in the
analyses. Global tests for heterogeneity between the provinces were not statistically significant (P>0.05). CHNS, China Health and Nutrition Survey; MAF, minor allele
frequency.
https://doi.org/10.1371/journal.pgen.1007275.t002
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Europeans with both HbA1c (P = 4.1x 10−7) and modified Stumvoll insulin sensitivity index
(P = 0.02) [38]. While power to detect associations is limited, data from the CHNS provide fur-
ther support for these established loci.
Association analyses for T2D validated (P<0.05) sixteen loci previously identified in East
Asians and/or Europeans (POU5F1/TCF19,SLC30A8,CUBN,MIR17HG, TMEM18,GLP2R,
GIPR, MC4R, BCL2L11, PAX4, IGF2BP2, PRC1, KCNQ1, CDKN2A/B,TLE4, and PAM/
PPIP5K2; S7 Table) [4, 26, 39–41], and did not reveal any genome-wide significant loci. Of the
validated loci, the most significant are at SLC30A8 (rs3802177, P = 3.0 x 10−4) and POU5F1/
TCF19 (rs2073721, P = 2.3 x 10−4). The three most significant variants not described previously
were located near RTN4RL1 (rs62069176, P = 2.7 x 10−7), SOCS6, (rs2581685, P = 2.6 x 10−6),
and ARID1B (rs6557473, P = 3.3 x 10−6) (S8 Table, S8 Fig). Of these, prior suggestive associa-
tions (P<0.05) have been detected previously between rs6557473 at ARID1B and both fasting
insulin and T2D in Europeans [9, 42, 43]. The CHNS data provide suggestive evidence for
these loci.
Annotating association signals with eQTL data
To aid in the identification of candidate genes at the strongest association signals, we examined
whether any of the variants associated with glycemic traits are also associated with expression
of nearby transcripts in pancreatic islets, blood, subcutaneous adipose, or tissues from GTEx
(S9 Table) [44–46]. These expression quantitative trait locus (eQTL) datasets were generated
predominantly from European ancestry donors. GWAS and eQTL signals more clearly coin-
cide when the GWAS variant and the variant most strongly associated with expression level of
the corresponding transcript exhibit high pairwise LD (r2>0.80). To allow for differences in
LD patterns across ancestries in the GWAS and eQTL datasets, we considered GWAS and
eQTL signals to be possibly coincident at a less stringent threshold for pairwise LD values
(r2>0.60, East Asian 1000G Phase 3). The association signal for fasting glucose in East Asians
at the SIX3-SIX2 locus contained fifteen variants meeting this criterion (lead GWAS variant
rs895636 and fourteen variants with East Asian LD r20.60), and the association signal for
islet SIX3 expression in Europeans contained 14 variants (lead variant and 13 variants with
European LD r20.60) (Fig 3B, S9 Table). One variant, rs12712928, exhibited high LD
(r2>0.80) with both the lead GWAS and eQTL variants (Fig 3C). rs12712928-C showed strong
association with higher fasting glucose (P = 3.4 x 10−8), similar to the lead fasting glucose
GWAS variant (rs895636, P = 2.3 x 10−8), and strong association with lower SIX3 expression
level in pancreatic islets (P = 4.7 x 10−8), similar to the lead SIX3 eQTL variant (rs12712929,
P = 1.7 x 10−8). In addition to SIX3, rs12712928-C was strongly associated with lower expres-
sion level of SIX2 (P = 1.4 x 10−4), SIX3-AS1 (P = 4.8 x 10−6), and two other long non-coding
transcripts (S9 Table) [47]. Assuming the fasting glucose GWAS and islet eQTL signals are
shared across ancestries, then the strongest candidate variant that may be responsible for both
associations is rs12712928.
Regulatory function of prioritized candidate regulatory variants
To establish a set of candidate functional variants at the SIX3-SIX2 locus, we used regulatory
chromatin marks (open chromatin and histone states) to predict which variants may affect the
transcription of nearby genes. Of 19 candidate variants at the SIX3-SIX2 locus (including the
lead GWAS variant rs895636, the lead islet eQTL variant rs12712929, variants in EAS LD
r2>0.60 with rs895636, and variants in EUR LD r2>0.6 with rs12712929), only five variants
(rs10192373, rs10168523, rs12712928, rs12712929, and rs748947) overlap pancreatic islet
active enhancer and pancreatic islet open chromatin (DNase or FAIRE) marks, as well as
CHNS glycemic trait GWAS and SIX2-SIX3 regulatory variant
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007275 April 5, 2018 8 / 24
predicted transcription factor binding motifs (S9 Fig). All five of these variants have EAS LD r2
0.66–0.87 with lead GWAS variant rs895636. These data suggest that these five variants are the
strongest candidates to affect transcription of the gene(s) at this locus.
To evaluate the allelic differences in enhancer activity of the five candidate functional vari-
ants, we conducted transcriptional reporter assays in MIN6 mouse insulinoma cells. We tested
4–6 independent constructs corresponding to each allele or haplotype for a 312-bp DNA region
located 18 kb downstream of SIX3 and 37 kb from the 3’ end of SIX2 spanning rs10192373,
rs10168523, rs12712928, rs12712929 (tested as a haplotype) and for a 365-bp region located 20
kb from the 3’ end of SIX3 spanning rs748947 (S9 Fig). While the rs748947 construct showed
no enhancer or allele-specific activity (S10 Fig), the haplotype construct had haplotype-differ-
ences in enhancer activity in both orientations (Fig 4A). This 4-variant construct containing
the fasting glucose-increasing alleles (rs10192373-A, rs10168523-G, rs12712928-C, and
rs12712929-T) showed significantly decreased enhancer activity of 1.4-fold in magnitude
(forward, P = 0.0008; reverse, P = 0.0001) compared to the haplotype containing the non-risk
alleles. To determine whether rs12712928 could account for the allele-specific effects, we used
site-directed mutagenesis to create two additional haplotype constructs. Haplotype constructs
containing rs12712928-C exhibited a 1.5-fold decrease in enhancer activity compared to the
haplotype constructs containing rs12712928-G (Fig 4B). Taken together, these data show that
rs12712928 exhibits allelic differences in transcriptional enhancer activity and suggest it func-
tions within a cis-regulatory element at the SIX3-SIX2 fasting glucose-associated locus.
We next asked whether alleles of rs12712928 or the other three variants differentially affect
DNA binding to nuclear proteins. A DNA-protein complex specific to the rs1272928-C allele
was observed using electrophoretic mobility shift assays (EMSA) with MIN6 nuclear lysate
(S10 Table, S11–S12 Figs). Competition with excess unlabeled C-allele probe more efficiently
competed away allele-specific bands than excess unlabeled G-allele probe, providing further
support for allele-specificity of the protein-DNA complexes (Fig 4C). Based on these results,
we hypothesized that rs12712928-C is located in a binding site for a transcriptional regulatory
complex that may be disrupted by the rs12712928-G allele. The sequence containing
rs12712928-C is predicted to include a consensus core-binding motif for several transcription
factors, and a ChIP-seq peak for CTCF also overlaps this region [48–50]. To identify transcrip-
tion factor(s) binding to rs12712928, we used a DNA-affinity capture assay. A protein band
showing allele-specific binding to the C allele was identified as the alpha subunit of GABP
using MALDI TOF/TOF mass spectrometry. In EMSA supershift assays using antibodies to
GABP-α, we observed a supershift of the allele-specific band (Fig 4C), suggesting that GAPB
may act as a repressor to reduce enhancer activity at this locus (Fig 4D).
We used a similar approach to identify potentially functional variants at the G6PC2 locus.
The first signal is comprised of two intergenic variants (GWAS index variant and one variant
in LD r2 >0.80). GWAS variant, rs34177044, is ~3.2 kb upstream from the transcription
start site of G6PC2 and does not overlap any predicted open chromatin marks. rs1402837
(LD r2 = 0.97) is located 646 bp upstream of the G6PC2 transcription start site and 187 bp and
208 bp upstream, respectively, of other promoter variants previously shown to exhibit allelic
differences on transcriptional activity, rs573225 and rs2232316 (S13 Fig) [51]. rs1402837 also
overlaps open chromatin marks, suggesting rs1402837 may play a regulatory role in fasting
glucose levels in the context of other G6PC2 promoter variants.
Discussion
In this study of genetic associations with T2D and related glycemic traits in Chinese individu-
als from 9 provinces in the CHNS, we observed associations with fasting glucose at SIX3-SIX2
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and G6PC2, including a coding variant representing an additional signal at G6PC2. We also
showed that the SIX3-SIX2 fasting glucose locus colocalizes with eQTL associations for SIX3,
SIX2, SIX3-AS1, RP11-89K21.1, and AC012354.6 in pancreatic islets, and we showed evidence
that rs12712828 functions as a regulatory variant at the SIX3-SIX2 fasting glucose locus.
Fig 4. rs12712928 exhibits allelic differences in transcriptional activity and protein binding. (A) A haplotype of four variant alleles associated with lower
fasting glucose, GAGG, at rs10192373, rs10168523, rs12712928, and rs12712929 repeatedly showed greater transcriptional activity in both forward and reverse
orientations with respect to SIX3 in MIN6 mouse insulinoma cells compared to the AGCT haplotype and an “Empty Vector” containing a minimal promoter.
(B) Analysis of additional haplotypes created by site-directed mutagenesis of rs127129258 alleles show that haplotypes containing, rs12712928-C (GACG and
AGCT), exhibited less transcriptional activity than haplotypes containing rs12712928-G (GAGG and AGGT) in the forward orientation. (C) EMSA with biotin-
labeled probes containing the C or G allele of rs12712928 show an allele specific band (arrow; lane 7 versus 2) that is competed away more effectively by 45-fold
excess of unlabeled probe containing the C allele (lane 8) than the G allele (lane 9). An arrow points to an allele-specific protein complex binding to the C allele.
We observed a supershift with the addition of antibodies to the alpha subunit of GABP (denoted by ). (D) Model of rs12712928 as a functional regulatory
variant at the SIX3-SIX2 locus. Alleles, including rs12712928-C, are associated with higher fasting plasma glucose levels and lower expression of SIX3 and other
transcripts in human pancreatic islets. Arrows indicate the transcription start site (TSS) of the SIX3 and SIX2 genes. An oval represents GABP bound
differentially to rs12712928-C, which exhibited lower transcriptional reporter activity compared to rs12712928-G.
https://doi.org/10.1371/journal.pgen.1007275.g004
CHNS glycemic trait GWAS and SIX2-SIX3 regulatory variant
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007275 April 5, 2018 10 / 24
Genetic associations in CHNS also supported (P<0.05) previously reported associations at 6,
2, 9, and 16 loci with fasting glucose, fasting insulin, HbA1c, and T2D, respectively. The mod-
erate sample size of CHNS prohibited us from identifying additional associations.
Hundreds of genes contribute to the heritability of complex traits [52]. As more GWAS and
genome-wide meta-analyses are conducted across genetically diverse populations, identifica-
tion of additional association signals and loci will help to explain the levels of heritability. The
CHNS adds to the growing number of population-based cohorts available for the study of met-
abolic traits. With its multi-provincial study design, the CHNS includes subjects of differing
ethnicities, from both urban and rural areas across China. Additionally, linkage of the geno-
type data with biomarkers and decades of longitudinal phenotype data (e.g. nutrition, health
outcomes, environment) will allow environmental and societal contributions to trait or disease
outcomes to be evaluated.
Alterations in regulatory elements or the coding sequence of G6PC2 can impact levels of
fasting plasma glucose. G6PC2 encodes an enzyme belonging to the glucose-6-phosphatase cat-
alytic subunit family responsible for the terminal step in gluconeogenic and glyconeogenic
pathways that lead to the release of glucose into the bloodstream [53]. Several previous studies
have identified >1 fasting glucose association signals at this locus in populations of European
and African ancestries, two of which include nonsynonymous coding variants [25, 26, 31, 33,
54–57]. We identified two distinct signals at G6PC2 associated with fasting plasma glucose lev-
els. Variants within the primary CHNS association signal have been associated with fasting
glucose in East Asian populations previously [11]. The lead variant in the second signal at
G6PC2 (rs2232326) is a missense variant (S324P). We were unable to assess evidence of associ-
ation with other coding variants in G6PC2 as the variants were either monomorphic in CHNS
or did not pass quality control thresholds.
To date, the association between variants near SIX3 and glycemic traits remains specific
to East Asian populations. rs895636 was reported as the lead variant associated with fasting
plasma glucose in a GWAS of >17,000 Korean and Japanese subjects (P = 9.9x10-13) and in
a separate GWAS meta-analysis of up to 46,085 East Asians (P = 2.5x10-13) [27]. However,
in Europeans, nominal to no association has been observed between rs895636 and fasting
glucose (P = 0.002, n>96,000) [33], HbA1c (P = 0.05, n>46,000) [36], fasting insulin
(P = 0.73, n>96,000) [33], and T2D (P = 0.41, n>120,000) [3]. Allele frequency is a possible
explanation for ancestry differences. In East Asians, the MAF of rs895636 is 0.42 while the
MAF in Europeans is only 0.16. Larger sample sizes of European-ancestry individuals may
be needed to identify the association between variants at the SIX3-SIX2 locus and glycemic
traits. Other genetic and environmental factors may also be playing a role in the fasting
glucose association at SIX3-SIX2 in East Asian populations that are not present in other
populations.
We provide compelling evidence that rs12712928 is a regulatory variant at the SIX3-SIX2
fasting glucose locus. The rs895636-T allele is associated with increased fasting glucose
levels and decreased SIX3, SIX2, and other transcript expression in pancreatic islets [47].
rs12712928 is in high LD (East Asian and European r2>0.87) with both rs895636 and the
lead pancreatic islet eQTL variant, rs12712929, and was the strongest candidate for an effect of
regulatory function based on its location in a putative islet enhancer element. Compared to
rs12712928-G, the allele rs12712928-C demonstrated decreased transcriptional activity, as well
as allele-specific binding to the alpha subunit of GABP, which suggests that at least GABP, and
possibly other transcription factors, bind to the C allele and repress expression of SIX3 and
SIX2. rs12712928 may be responsible for the GWAS signal, or given that some GWAS signals
are affected by multiple functional variants [58, 59], other variants at this locus may also con-
tribute to variation in fasting glucose.
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SIX3 is a strong candidate for a target gene at the SIX3-SIX2 fasting glucose locus. Highly
expressed in pancreatic islets [44], SIX3 encodes sine oculis homeobox-like protein 3, a tran-
scription factor that localizes to the nucleus of adult beta cells to regulate insulin production
and secretion. Decreased expression of SIX3 results in the misregulation (i.e. decreased levels)
of insulin [60], which promotes the uptake of glucose into fat, liver, and skeletal muscle cells,
thus lowering blood glucose levels [61]. Consistent with the effects of SIX3 in mice, the risk
allele rs12712928-C is associated with both decreased expression of SIX3 and increased levels
of fasting glucose. In CHNS, rs12712928-C was also moderately associated with decreased fast-
ing insulin levels (P = 7.6x10-5) and an increased risk for T2D (P = 0.03). However, in the islet
eQTL data, rs12712928 was also associated with expression level of SIX2, SIX3-AS1, RP11-
89K21.1, and AC012354.6. SIX2 is also believed to play a role in the regulation of islet beta cell
functions such as insulin output [60]; however, less is known about its biologic function com-
pared to SIX3. Additionally, the roles of SIX3-AS1, RP11-89K21.1, and AC012354.6 are not well
characterized. One or more of these transcripts could be a target gene underlying the associa-
tion signal and contributing to the biological effect on fasting glucose.
In conclusion, this study confirmed many previously identified loci associated with T2D
and related glycemic traits and validated a recently described G6PC2missense variant associ-
ated with fasting glucose. We report a functional variant at the SIX3-SIX2 locus, rs12712928,
and provide evidence of a potential mechanism by which this variant affects expression of at
least SIX3, leading to decreased levels of fasting glucose. Our use of a denser reference panel of
>8 million variants in a diverse Chinese population allowed us to conduct higher resolution
genetic analyses than reported previously. Further functional analyses of the variants identified
in this study is the next step to confirm which variants and genes are affected. Replication of
the moderately-significant associations would be useful to better understand the genetic archi-
tecture of glycemic traits.
Materials and methods
The China Health and Nutrition Survey
The China Health and Nutrition Survey (CHNS) is a nationwide, longitudinal survey aimed at
examining economic, sociological, demographic, and health questions in a Chinese popula-
tion. Details of subject selection and study design have been described elsewhere [12]. Briefly,
a stratified probability sample with a multistage, random cluster design was used to select
counties and cities within 9 diverse provinces (Guangxi, Guizhou, Heilongjiang, Henan,
Hubei, Hunan, Jiangsu, Liaoning, and Shandong), stratified by income and urbanicity using
State Statistical Office definitions. A total of 4,560 households from 228 communities were
then randomly selected from within each stratum. Health data was collected during nine
rounds of surveys from 1989–2011 (1989, 1991, 1993, 1997, 2000, 2004, 2006, 2009, and 2011).
The 2009 survey was the first to collect fasting blood samples. The CHNS was approved by the
Institutional Review Boards at the University of North Carolina at Chapel Hill (#07–1963,
#05–2369), the Chinese National Human Genome Center at Shanghai (#2017–01), and the
Institute of Nutrition and Food Safety at the China Centers for Disease Control (#201524–1).
All participants provided written informed consent.
The present analysis was limited to subjects who participated in the 2009 survey round and
for whom blood biomarker traits were available (n = 9,551). For the glucose and insulin analy-
ses, subjects were only included if their blood sample was obtained after an overnight fast
(n = 6,779). Subjects were excluded from a particular analysis if their biomarker trait value
exceeded 4 standard deviations beyond the group mean or have type 1 diabetes. Fasting blood
samples were not required for the HbA1c or T2D analysis. Additionally, one member of each
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first-degree relative pair was randomly removed for analyses of T2D, as current software to
analyze associations with binary traits do not control for the high number of related individu-
als with CHNS.
Glycemic trait measurements
Following an overnight fast, a blood sample (12 mL) was collected by venipuncture. Glucose
and insulin were measured in the central laboratory of the China-Japan Friendship Hospital.
Detailed descriptions of the laboratory procedures for measuring glucose (GOD-PAP
method; Randox Laboratories Ltd, UK), and insulin (radioimmunology in a gamma counter,
XH-6020 analyzer; North Institute of Bio-Tech, China), levels have been described previ-
ously [62]. HbA1c was measured in the central laboratory of the China-Japan Friendship
Hospital [Guizhou and Hunan, HLC method, HLC-723 G7 (machine), Tosoh, Japan
(reagent). Theory: Boronic Acid Afinity HPLC] or in the field [Guangxi and Henan: HPLC
method, Primus Ultra 2 (PDQA1c), Primus, USA; Heilongjiang, Hubei, Jiangsu, and Liao-
ning: HLP method, Bio-Rad (D10), Bio-Rad, USA; Shandong: HLC method, HLC-723 G7,
Tosoh, Japan. Theory: Ion exchange HPLC]. Different methods and machines were cali-
brated with the same quality control products made in Bio-Rad, USA. Participants were clas-
sified as having T2D if they were at least 18 years old and met at least one of the following
criteria: 1) HbA1c6.5%, 2) fasting blood glucose126 mg/dL, 3) received the diagnosis
from a physician after the age of 20 (self-report), or 4) reported taking diabetes medication
(self-report) (S1B Table).
Genotyping and quality control
DNA samples were extracted and genotyped at the Chinese National Human Genome Center,
Shanghai, China. Genotyping was performed with the Illumina HumanCoreExome chip using
the standard protocol recommended by the manufacturer. Genotyping was attempted on the
10,131 unique samples, 316 duplicates, and 1 set of triplicates (total n = 10,449). 1,513 samples
were unable to be genotyped due to inadequate DNA concentrations (<10 ng/uL or OD 260/
280 outside the 1.5–2.0 range), and an additional 69 samples were excluded for poor quality.
Using KING, we identified 7 pairs of samples that were unintentionally duplicated; one sample
from each pair was excluded. We used PLINK v.1.9 to compare genotype heterozygosity on
the X chromosome to self-reported gender and excluded 129 mismatched samples and six
samples with apparent XXY or XXXY genotypes. The CHNS data contained 4 sets of identical
twins; 1 subject was randomly excluded from each twin pair. Finally, based on the principal
component analysis described below, we excluded two samples that were outliers from Hap-
Map samples of Han Chinese in Beijing, China (CHB), Chinese in Metropolitan Denver,
Colorado (CHD), and Japanese in Tokyo, Japan (JPT). After exclusions, 8,403 samples were
successfully genotyped and passed all genotyping quality control.
We applied variant quality control checks in PLINK v.1.9 on the 8,403 remaining CHNS
samples that were successfully genotyped. Of the initial 538,448 variants, we discarded 4,306
variants due to call rate<95% and/or deviation from Hardy-Weinberg equilibrium (P<10−6).
Of the remaining 534,143 variants, 193,236 (36.2%) were monomorphic and 340,906 (63.8%)
were polymorphic.
Because of the household-based study design of CHNS, we expected the CHNS to include
many first- and second-degree relatives. Using KING [63], we calculated kinship coefficients
for all pairwise relationships and identified 3,681 first-degree relative pairs and 1,567 second-
degree relative pairs.
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Genotype imputation
We performed genotype imputation of the autosomal chromosomes of 8,403 samples with the
1000 Genomes Project Phase 3 v5 reference panel [13, 64] using the Michigan Imputation
Server [65]. We used Eagle2 [66] for pre-phasing, followed by imputation with Minimac3 soft-
ware. We also imputed the X chromosome using with the 1000 Genomes Project Phase 3 v5
reference panel. We imputed male (n = 3,927) and female (n = 4,476) samples separately,
using Mach for pre-phasing and Minimac2 for imputation. Imputation yielded data for
47,095,001 variants, and the 534,143 directly genotyped variants were also assigned imputed
genotypes. We removed variants with an imputation r2 <0.30 (35,615,501 variants) or a MAF
<0.01 (37,891,969 variants) as additional quality control procedures. In total, we tested
8,045,193 variants for association with fasting glucose, insulin, and HbA1c levels and T2D.
Accounting for population substructure
We constructed principal components (PCs) to capture population substructure among the
CHNS subjects. We identified a set of 55,601 independent variants with MAF > 0.05 and pair-
wise LD r2 <0.02 in a sliding window of 50 variants and used the variants to construct PCs in
8,403 CHNS subjects (Fig 1; S1–S3 Figs). The set of 55,601 variants was trimmed to match a
list of 47,032 variants that were also available in HapMap Phase III samples. Individuals from
CHNS and HapMap III were plotted based on the first two eigenvectors produced by the PC
analysis (S1 Fig). We tested for the association between each of the first 10 PCs and each of the
phenotypic traits to identify PCs associated at P<0.05; the first PC was included as a covariate
in the regression models.
Genome-wide association analysis
Fasting glucose, fasting insulin, HbA1c, and T2D were adjusted for age, age2, BMI, gender, and
PC1. Residuals were then inverse normal-transformed to satisfy model assumptions of normal-
ity. Efficient mixed model associations (EMMAX) accounting for population structure and
relatedness were performed using EPACTs v.3.1.0 [24]. Because EMMAX was designed for
analysis of linear traits, GWA analyses for T2D were performed using the Firth bias-corrected
logistic regression likelihood ratio test implemented in EPACTs [67]. For all analyses, genotype
was modeled as an additive effect, with the genotype dosage values used as the primary predic-
tor of interest. Due to the correlation of the glycemic traits, we used a genome-wide signifi-
cance threshold of P<5 x 10−8 to define a single result as genome-wide significant, as used in
previous association studies of this scale and high trait correlation [68]. A conservative experi-
ment-wide Bonferroni-corrected P-value for four could be considered as P<1.25x10-8. We cre-
ated regional association plots using LocusZoom [69] with LD estimates generated from the
CHNS subjects. All variant positions correspond to build hg19.
Conditional analyses
At loci that exhibited evidence of genome-wide significant association (P<5 x 10−8), we iden-
tified additional association signals using conditional analysis. We added the most strongly
associated variant into the regression model as a covariate and tested all remaining regional
variants (+/- 1 Mb from the initial lead GWA variant at each locus) for association. Since we
were focusing on a much narrower region of variants during the conditional analyses, we set a
less stringent locus-significance threshold of P<1 x 10−5 based on ~5,000 variants in a 2 Mb
region. We performed sequential conditional analyses until the strongest variant no longer
met the P-value threshold.
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Associations with other metabolic traits and outcomes
We used summary data available in the Type 2 Diabetes Knowledge Portal [70] to explore
associations between the newly identified loci and other metabolic traits and outcomes. Asso-
ciation summary statistics available (last assessed June 23, 2017) included coronary artery
disease from CARDIoGRAM [71]; kidney-related traits from CKDGen [72]; T2D from DIA-
GRAM, GoT2D, BioMe AMP, CAMP, and SIGMA [3, 43, 73–75]; BMI and waist-hip-ratio
from GIANT [76, 77]; and glycemic traits from MAGIC [26, 36, 78, 79]. Additionally, we used
data available from the ICP-GWAS (systolic and diastolic blood pressure) [80] and the AGEN
adiponectin GWAS [81]. To identify variants in high LD (r2>0.80) with the lead variants, we
used LDlink with all East Asian sample populations from the 1000 Genomes Project as the ref-
erence [82].
Regulatory element annotation
We used ENCODE [15], ChromHMM [83], and Human Epigenome Atlas [84] data available
through the UCSC Genome Browser to determine which of the candidate variants in each
association signal overlapped open-chromatin peaks, ChromHMM [83] chromatin states,
and chromatin-immunoprecipitation sequencing (ChIP-seq) peaks of histone modifications
H3K4me1, H3K4me3, and H3K27ac, and transcription factors in pancreatic islets and the
pancreas.
Expression quantitative trait loci (eQTL)
We searched the following publicly available eQTL databases to identify cis-eQTLs at the
observed loci: GTEx v7 [85], the University of Chicago eQTL browser [86], the Islet eQTL
Explorer (http://theparkerlab.org/tools/isleteqtl/) [47], and the Blood eQTL Browser [45]. We
also searched for cis-eQTLs in subcutaneous adipose tissue from the METSIM study [87]. All
eQTL data sources used a false discovery rate (FDR) <5% for identifying cis-eQTLs, with the
exception of the METSIM study, which used an FDR <1%.
Cell culture
MIN6 mouse insulinoma cells[88] were cultured in DMEM (Sigma) supplemented with 10%
FBS, 1 mM sodium pyruvate, and 0.1 mM beta-mercaptoethanol. The cell cultures were main-
tained at 37˚C with 5% CO2.
Transcriptional reporter assays
To measure variant allelic differences in enhancer activity at the SIX3-SIX2 locus, we designed
oligonucleotide primers (S10 Table) with KpnI and XhoI restriction sites, and amplified the
312-bp DNA region (GRCh37/hg19 –chr2: 45,191,902–45,192,213) around: rs10192373,
rs10168523, rs12712928, rs12712929 (tested as a haplotype). Separately, we amplified a 365-bp
region (GRCh37/hg19 –chr2:45,192,357–45,192,721) around rs748947. The 312-bp haplotype
construct was altered to create a missing haplotype for rs12712928 using the QuickChange site
directed mutagenesis kit (Stratagene). As previously described [19], we ligated amplified DNA
from individuals homozygous for each allele into the multiple cloning site of the luciferase
reporter vector pGL4.23 (Promega) in both orientations with respect to the genome. Isolated
clones were sequenced for genotype and fidelity. 2x105 MIN6 cells were seeded per well, and
grown to 90% confluence in 24-well plates. We co-transfected five independent luciferase con-
structs and Renilla control reporter vector (phRL-TK, Promega) using Lipofectamine 2000
(Life Technologies) and incubated for another 48 hours. 48 hours post-transfection, the cells
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were lysed with Passive Lysis Buffer (Promega). Luciferase activity was measured using the
Dual-luciferase Reporter Assay System (Promega) per manufacturer instructions and as previ-
ously described [19].
Electrophoretic mobility shift assay (EMSA)
Nuclear cell protein was extracted from MIN6 cells using the NE-PER nuclear extraction kit
(Thermo Scientific). 17 bp oligonucleotide probes were designed centered on each variant:
rs10192373, rs10168523, rs12712928, and rs12712929 (S10 Table). The annealed double-
stranded oligonucleotide biotin labeled and unlabeled probes for both alleles were generated
as previously described [19]. To conduct EMSAs, we used the LightShift Chemiluminescent
EMSA Kit (ThermoFisher Scientific) and followed the manufacturer’s recommendations.
Briefly, a 20 μl binding reaction consisting of 6 μg nuclear extract, 1X binding buffer, 50 ng/μL
poly (dI-dC), and 200 fmol of labeled probe was incubated at room temperature for 25 min-
utes. For competition reactions, 25-fold excess of unlabeled probe for either allele were
incubated for 15 min prior to the addition of 200 fmol labeled probe and incubated for an
additional 25 minutes. For supershift assays, 6 μg of polyclonal GABP-α antibody (sc28312X;
Santa Cruz Biotechnology) was added to the binding reactions and incubated for 25 minutes
prior to the addition of 200 fmol labeled probe. The reaction was further incubated for an
additional 25 minutes. Protein-probe complexes were resolved on non-denaturing PAGE on
6% DNA retardation gels (Thermo Scientific), transferred to Biodyne B nylon membranes
(PALL Life Sciences), cross-linked on a UV-light cross linker (Stratagene), and detected by
chemiluminescence. EMSAs were carried out on second independent day and yielded compa-
rable results.
Identification of proteins binding rs12712928
To identify factors in the protein complex binding rs12712928, we conducted a DNA affinity
capture assay as previously described [19]. Briefly, the 450 μL binding reactions consisted of
300 μg of pre-cleared, dialyzed MIN6 nuclear extract, 1X binding buffer, 50 ng/μL poly (dI-
dC), and 40 pmol of biotin-labeled probe for either rs12712928 allele (same as EMSA probes)
or a scrambled control. Binding reactions were incubated at room temperature for 30 min on
a rotator, and then 100 μL of streptavidin-magnet Dynabeads were added to the reaction and
incubated for an additional 20 minutes. Beads were washed and bound DNA-proteins were
eluted in 1X reducing sample buffer. Proteins were separated on NuPAGE denaturing gel and
allelic differences in protein bands was visualized with Coomassie G-250 staining. The UNC
Michael Hooker Proteomics Center used a Sciex 5800 MALDI-TOF/TOF mass spectrometer
to identify the proteins in the excised protein bands.
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S1 Fig. Principal components analysis of allele frequency for CHNS (black) compared to
other samples included in the International HapMap Project Phase 3. (A) All samples. (B)
A subset of populations with East Asian ancestry.
(AI)
S2 Fig. Principal components analysis of allele frequency for the China Health and Nutri-
tion Survey by province. Dots representing each subject are colored by the province in which
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they reside. Smaller plots show individuals from each province separately.
(AI)
S3 Fig. Principal components analysis of allele frequency for the China Health and Nutri-
tion Survey by ethnicity. Dots representing each subject is colored by their self-reported eth-
nicity. Smaller plots show individuals for each ethnicity separately.
(AI)
S4 Fig. Flow chart of study design and sample sizes for association analyses. Of 8,403 sub-
jects with genome-wide genotyping data after quality control, we analyzed 5,786 nondiabetic,
fasting individuals for glucose and insulin; 6,943 nondiabetic individuals for HbA1c; and 5,731
non-first-degree relatives for type 2 diabetes.
(AI)
S5 Fig. Fasting glucose locus near SIX3-SIX2 exhibits one association signal in the CHNS.
(A) The purple diamond represents rs895636, the strongest associated variant in the initial
unconditioned analysis of fasting glucose. (B) No additional association signals persist after
conditioning on rs895636. Other variants are colored based on LD with the lead variant within
8,403 CHNS subjects.
(AI)
S6 Fig. Regional association plot of strongest fasting insulin association signal located near
CNTN6. The purple diamond represents the lead variant, rs13078376, which exhibited the
strongest evidence of association at the locus among 1000 Genomes Project Phase 3-imputed
variants. Other variants are colored based on LD with the lead variant within 8,403 CHNS sub-
jects.
(AI)
S7 Fig. Regional association plot of strongest HbA1c association signal in CHNS located
near FN3KRP. The purple diamond represents the lead variant, rs9895455, which exhibited
the strongest evidence of association at the locus among 1000 Genomes Project Phase
3-imputed variants. Other variants are colored based on LD with the lead variant within 8,403
CHNS subjects. Arrows indicate a previously reported variant.[10, 37].
(AI)
S8 Fig. Regional association plots of the strongest T2D loci identified in the CHNS. (A)
RTN4RRL1, (B) SOCS6, (C) ARID1B. The purple diamond represents the lead variant, which
exhibited the strongest evidence of association at the locus among 1000 Genomes Project
Phase 3-imputed variants. Other variants are colored based on LD with the lead variant within
8,403 CHNS subjects. A nominal association (P = 0.04) has been detected between a variant at
ARID1B and T2D.[43].
(AI)
S9 Fig. Chromatin marks in pancreatic islets in the intergenic region between SIX3 and
SIX2. UCSC Genome Browser (hg19) diagram showing the location of the lead fasting glucose
variant, rs895636, and other candidate variants. SIX3 is transcribed from left to right, while
SIX2 is transcribed from right to left. The region expanded below spans all candidate variants,
including the lead GWAS variant, all variants in high LD (East Asian r2>0.80) with the
lead GWAS variant, the lead European pancreatic islet eQTL variant (rs12712928), and all var-
iants in high LD (European r2>0.80) with the lead eQTL variant. rs12712928, rs12712929,
rs10168523, and rs748947 overlap regions of accessible chromatin in human pancreatic islets
detected by H3K9ac ChIP-seq. Tested candidate regulatory elements (CREs) are represented
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by horizontal black rectangles in the lower figure.
(AI)
S10 Fig. rs748947 at the SIX3-SIX2 locus does not exhibit allelic differences in transcrip-
tional activity in MIN6 mouse insulinoma cells. rs748947 is a proxy of rs895636 and
rs12712928, but does not appear to contribute to transcriptional activity differences at this locus.
(AI)
S11 Fig. Allele-specific binding of DNA-protein complexes in MIN6 nuclear extract for
four candidate variants at SIX3-SIX2. Probes spanning each allele were incubated with
MIN6 nuclear lysate and subjected to electromobility shift assay (EMSA). The only band indic-
ative of a DNA-protein complex was observed for allele C of rs12712928.
(AI)
S12 Fig. (A) Allele-specific binding of DNA-protein complexes in MIN6 nuclear extract for
four candidate variants at SIX3-SIX2. Probes spanning each allele were incubated with MIN6
nuclear lysate and subjected to electromobility shift assay (EMSA). The only band indicative
of a DNA-protein complex was observed for allele C of rs12712928. (B) EMSA with biotin-
labeled probes containing the C or G allele of rs12712928 show an allele specific band (arrow;
lane 7 versus 2) that is competed away more effectively by 45-fold excess of unlabeled probe
containing the C allele (lane 8) than the G allele (lane 9).
(PDF)
S13 Fig. Chromatin marks in pancreatic islets spanning of the two fasting glucose-associ-
ated signals near G6PC2. (A) Signal 1. The variant with the strongest association with fasting
glucose, rs34177044, and the only variant in high LD (r2>0.80), rs1402837, are shown. Variant
rs1402837 is located in a region with evidence of regulatory potential at the G6PC2 promoter,
overlapping regions of accessible chromatin in human pancreatic islets detected by H3K4me3
ChIP-seq. Tested candidate regulatory elements (CREs) are represented by horizontal black
rectangles. (B) Signal 2. Variant rs2232326 is situated in the last exon of G6PC2 and encodes
Ser324Pro. The two additional variants in high LD (r20.80) with rs2232326 are located
downstream within an intron of ABCB11. One variant, rs13387347, was previously reported to
be associated with fasting glucose in East Asians.
(AI)
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